Abbott Makes Three, Not Two, Investments In AFib Ablation
This article was originally published in The Gray Sheet
Executive Summary
Abbott made a minority equity investment in VytronUS as part of the startup's latest funding round, according to the VytronUS' biggest institutional investor. That comes in addition to an acquisition and a right-to-purchase transaction for two other atrial fibrillation ablation firms, marking Abbott's entry into that market.